Peter Mutzenbecher
Regional Vice President, General Manager Geschäftsführer Germany @Incyte
Signup · Get unlimited contacts
WORK HISTORY
Regional Vice President, General Manager Geschäftsführer Germany @Incyte
Munich, DE
Building the organization from 1 product and 15 FTE to 4 products, 2 BUs and close to 100 FTE, resulting in a more than 10fold increase in net revenue and even more positive evolution of financial contribution; direct reporting lines with BUD, MD (incl Clin Ops), Access, Public Aff, Business Effectiveness, Operations, dotted line with Legal, Finance, HR- Leading Onco-Hematology team through AMNOG and towards successful launches of 2 new products (EU Awards for best performance) and acceleration of in-line business- Building the Inflammation and Auto-Immunity (IAI) team from zero to launch first ever approved treatment for Vitiligo in 23 - Developing high-performing leadership team, incl talent development into German Leadership role and into EU roles- Member of the Ex-US LT, Leader of regional Organization Effectiveness Domain
EDUCATION
University of Mannheim
Diplom-Kaufmann, Betriebswirtschaftslehre
Universitat Autònoma de Barcelona
Betriebswirtschaftslehre
CEDEP / INSEAD
General Management Program
ABOUT PETER MUTZENBECHER
I am a biotech and pharma executive with 20+ years of leadership experience across Europe, LATAM, and global HQ roles. My passion lies in building and scaling organizations, launching innovative therapies, and forming teams that deliver outstanding results, helping organizations unlock their full potential. KEY ACCOMPLISHMENTS- 10+ years in General Management (8 years in Germany), across biotech and big pharma - 20+ launches in Oncology, Hematology, Auto-Immune, Rare Diseases, Specialty Care - incl. AMNOG Germany - Scaled a biotech affiliate in Germany from 1 product to 4 products - Transformed big pharma affiliate from single cash cow to diversified growth portfolio - Full P&L responsibility >€250M with strong lifecycle and portfolio management expertise - Passion for people development — multiple promotions into local leadership teams and international roles - Successfully piloted (for EU), built and managed company alliances with >300 people engaged, e.g. alliances with AZ (Diabetes) and Pfizer (CV, e.g. Eliquis) at BMS. KEY SKILLS: People leadership and team building; strategic thinking and execution in biotech; scaling organizations and managing change; launch of innovative therapies; P&L management; strategic alliances and acquisition integration; European Market Access (incl. AMNOG expertise) navigation; stakeholder engagement; talent development LANGUAGES: German (native), English (fluent), Spanish (fluent), French (basic), Catalan (basic) PASSIONATE ABOUT…- Bringing highly innovative medicines to patients to help them prevail over serious conditions - Scaling and transforming biotech organizations for global impact - Building and leading high-performing, diverse teams - Advancing the biotech landscape through strategic innovation KEYWORDS: General Management | Country Manager | Chief Business Officer | VP Commercial | Fractional CBO | Interim Leadership | Biotech | Pharma | Oncology | Hematology | Immunology | Rare Diseases | Specialty Care | Market Access | AMNOG | P&L Management | Commercial Strategy | Business Unit Leadership | Launch Excellence | Transformation | Strategic Alliances | Organizational Development | Talent Development | Leadership | Stakeholder Engagement | Alliance Management | Incyte | BMS | Bayer | BASF
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.